Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postprandial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants

Atherosclerosis

Volumn 152, Issue 2, 2000, Pages 317-325

  Tahvanainen, Esa ^a   Molin, Mika ^a   Vainio, Saara ^a   Tiret, Laurence ^b   Nicaud, Viviane ^b   Farinaro, Eduardo ^c   Masana, Luis ^d   Ehnholm, Christian ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b INSERM   (France)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Hospital Universitari   (Spain)

Author keywords

Atherosclerosis; European Atherosclerosis Research Study; Intestinal fatty acid binding protein; Polymorphism

Indexed keywords

FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CODON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; EUROPE; FAMILY HISTORY; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; MULTICENTER STUDY; NORMAL HUMAN; PRIORITY JOURNAL; STUDENT;

ADOLESCENT; ADULT; ARTERIOSCLEROSIS; BLOOD GLUCOSE; CARRIER PROTEINS; CODON; DIETARY FATS; FASTING; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INTESTINES; LIPIDS; MALE; MYOCARDIAL INFARCTION; NEOPLASM PROTEINS; POLYMORPHISM, GENETIC; POSTPRANDIAL PERIOD; TUMOR SUPPRESSOR PROTEINS;

EID: 0033816390     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00488-8     Document Type: Article

References (44)

1. Schleicher C.H., Cordoba O.L., Santome J.A., Dell'Angelica E.C. Molecular evolution of the multigene family of intracellular lipid-binding proteins. Biochem. Mol. Biol. Int. 36:1995;1117.
2. Glatz J.F., Luiken J.J., van Nieuwenhoven F.A., Van der Vusse G.J. Molecular mechanism of cellular uptake and intracellular translocation of fatty acids. Prostaglandins Leukot. Essent. Fatty Acids. 57:1997;3.
3. Glatz J.F., van Nieuwenhoven F.A., Luiken J.J., Schaap F.G., van der Vusse G.J. Role of membrane-associated and cytoplasmic fatty acid-binding proteins in cellular fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids. 57:1997;373.
4. Burnett D.A., Lysenko N., Manning J.A., Ockner R.K. Utilization of long chain fatty acids by rat liver: studies of the role of fatty acid binding protein. Gastroenterology. 77:1979;241.
5. Thompson A.B.R., Schoeller C., Keelan M., Smith L., Cladinin M.T. Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can. J. Physiol. Pharmacol. 71:1993;523.
6. Davidson N.O. Cellular and molecular mechanisms of small intestinal lipid transport. Johnson L.R. Physiology of the Gastrointestinal Tract. 3rd ed. 1994;1909-1934 Raven, New York.
7. Schroeder F., Jolly C.A., Cho T.H., Frolov A. Fatty acid binding protein isoforms: structure and function. Chem. Phys. Lipids. 92:1998;1.
8. Ockner R.K. A binding protein for fatty acids in cytosol of intestinal mucosa, liver, and other tissues. J. Clin. Invest. 51:1972;70. Abstract.
9. Ockner R.K., Manning J.A. Fatty acid-binding protein in small intestine. Identification, isolation, and evidence for its role in cellular fatty acid transport. J. Clin. Invest. 54:1974;326.
10. Ockner R.K., Manning J.A., Kane J.P. Fatty acid binding protein. Isolation from rat liver, characterization, and immunochemical quantification. J. Biol. Chem. 257:1982;7872.
11. Offner G.D., Brecher P., Sawlivich W.B., Costello C.E., Troxler R.F. Characterization and amino acid sequence of a fatty acid-binding protein from human heart. Biochem. J. 252:1988;191.
12. Peeters R.A., Veerkamp J.H., Geurts van Kessel A., Kanda T., Ono T. Cloning of the cDNA encoding human skeletal-muscle fatty-acid-binding protein, its peptide sequence and chromosomal localization. Biochem. J. 276:1991;203.
13. Baxa C.A., Sha R.S., Buelt M.K., Smith A.J., Matarese V., Chinander L.L., Boundy K.L., Bernlohr A. Human adipocyte lipid-binding protein: purification of the protein and cloning of its complementary DNA. Biochemistry. 28:1989;8683.
14. Madsen P., Rasmussen H.H., Leffers H., Honore B., Celis J.E. Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins. J. Invest. Dermatol. 99:1992;299.
15. Oelkers P., Dawson P.A. Cloning and chromosomal localization of the human ileal lipid-binding protein. Biochim. Biophys. Acta. 1257:1995;199.
16. Bennett E., Stenvers K.L., Lund P.K., Popko B. Cloning and characterization of a cDNA encoding a novel fatty acid binding protein from rat brain. J. Neurochem. 63:1994;1616.
17. Shimizu F., Watanabe T.K., Shinomiya H., Nakamura Y., Fujiwara T. Isolation and expression of a cDNA for human brain fatty acid-binding protein (B-FABP). Biochim. Biophys. Acta. 1354:1997;24.
18. Godbout R., Bisgrove D.A., Shkolny D., Day R.S. Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene. 16:1998;1955.
19. Gordon J.I., Elshourbagy N., Lowe J.B., Liao W.S., Alpers D.H., Taylor J.M. Tissue specific expression and developmental regulation of twogenes coding for rat fatty acid binding proteins. J. Biol. Chem. 260:1985;1995.
20. Sparkes R.S., Mohandas T., Heinzmann C., Gordon J.I., Klisak I., Zollman S., Sweetser D.A., Ragunathan L., Winokur S., Lusis A.J. Human fatty acid binding protein assignments intestinal to 4q28-4q31 and liver to 2p11. Cytogenet. Cell. Genet. 46:1987;697. Abstract.
21. Prochazka M., Lillioja S., Tait J.F., Knowler W.C., Mott D.M., Spraul M., Bennett P.H., Bogardus C. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes. 42:1993;514.
22. Mitchell B.D., Kammerer C.M., O'Connel P., Harrison C.R., Manire M., Shipman P., Moyer M.P., Stern M.P., Frazier M.L. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes. 44:1995;1046.
23. Baier L.J., Sacchettini J.C., Knowler W.C., et al. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95:1995;1281.
24. Hegele R.A., Harris S.B., Hanley A.J.G., Sadikian S., Connelly P.W., Zinman B. Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J. Clin. Endocr. Metab. 81:1996;4334.
25. Hegele R.A., Connelly P.W., Hanley A.J.G., Sun F., Harris S.B., Zinman B. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians. Arteriosler. Thromb. Vasc. Biol. 17:1997;1060.
26. Pihlajamaki J., Rissanen J., Heikkinen S., Karjalainen L., Laakso M. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 17:1997;1039.
27. Ågren J.J., Valve R., Vidgren H., Laakso M., Uusitupa M. Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler. Thromb. Vasc. Biol. 18:1998;1606.
28. The European Atherosclerosis research study (EARS): design and objectives. Int. J. Epidemiol. 23:1994;465.
29. Rosseneu M., Fruchart J.C., Bard J.M., Nicaud V., Vinaimont N., Cambien F., De Backer G. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. Circulation. 89:1994;1967.
30. Humphries S.E., Nicaud V., Margalef J., Tiret L., Talmud P. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides. Arteriosler. Thromb. Vasc. Biol. 18:1998;526.
31. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
32. Syvänen A.C., Sajantila A., Lukka M. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. Am. J. Hum. Genet. 52:1993;46.
33. Tiret L., Nicaud V., Ehnholm C., Havekes L., Menzel H.J., Ducimetiére P., Cambien F. Inference of the strength of genotype-disease association from studies comparing offspring with and without parental history of disease. Ann. Hum. Genet. 57:1993;141.
34. Gangl A., Ockner R.K. Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control. J. Clin. Invest. 55:1975;803.
35. Bass N.M., Manning J.A., Ockner R.K., Gordon J.I., Seetharam S., Alpers D.H. Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. Influences of sex difference and of clofibrate. J. Biol. Chem. 260:1985;1432.
36. 13C NMR study. J. Biol. Chem. 264:1989;2700.
37. Glatz J.F., Borchers T., Spener F., van der Vusse G.J. Fatty acids in cell signalling: modulation by lipid binding proteins. Prostaglandins Leukot. Essent. Fatty Acids. 52:1995;121.
38. Sipilainen R., Uusitupa M., Heikkinen S., Rissanen A., Laakso M. Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J. Clin. Endocr. Metab. 82:1997;2629.
39. Saarinen L., Pulkkinen A., Kareinen A., Heikkinen S., Lehto S., Laakso M. Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM. Diabetes Care. 21:1998;849.
40. Sacchettini J.C., Gordon J.I. Rat intestinal fatty acid binding protein. J. Biol. Chem. 268:1993;18399.
41. Baier L.J., Bogardus C., Sacchettini J.C. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271:1996;10892.
42. Mansbach C.M., Nevin P. Intracellular movement of triacylglycerols in the intestine. J. Lipid Res. 39:1998;963.
43. Polymeropoulos M.H., Rath D.S., Xiao H., Merril C.R. Trinucleotide repeat polymorphism at the human intestinal fatty acid binding protein gene (FABP2). Nucleic Acids Res. 18:1990;7198.
44. Humphreys P., McCarthy M., Tuomilehto J., et al. Chromosome 4q locus associated with insulin resistance in Pima Indians. Studies in three European NIDDM populations. Diabetes. 43:1994;800.